MedTrace Logo

Brain SPECT Following Cialis (Tadalafil ) Administration

NCT01374347 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-02-09

No results posted yet for this study

Summary

The study will be an open label one and will include 30 patients who underwent ischemic stroke 3 month to 3 years prior to the study. All patients will undergone a baseline brain SPECT perfusion study. 15 patients will take one dose of 20 mg cialis, and will have a second brain SPECT 24 hours after cialis administration. 15 other patients (age and risk factor matched) will be prescribed 5 mg of cialis once daily for 7 days, and a second SPECT study will be performed 24 hours after the last dose.

Conditions

  • Change in Brain Perfusion

Sponsors & Collaborators

  • Wolfson Medical Center

    lead OTHER_GOV

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-07-31
Completion
2012-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01374347 on ClinicalTrials.gov